ROBERT W MANDAL
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology ELGIN, IL NPI 1124012901
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology IL NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$4,852.69
- Category: General Payments
- Program years: PY2018–2024
- Record count: 235
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,317.24 across 58 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,317.24 | 58 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $245.65 | 14 |
| Tempus AI, Inc | $187.04 | 8 |
| ABBVIE INC. | $145.13 | 7 |
| Gilead Sciences, Inc. | $109.44 | 5 |
| PFIZER INC. | $102.81 | 5 |
| Celgene Corporation | $101.34 | 3 |
| Daiichi Sankyo Inc. | $81.89 | 3 |
| Astellas Pharma US Inc | $71.50 | 2 |
| TerSera Therapeutics LLC | $69.44 | 2 |
| Incyte Corporation | $42.76 | 2 |
| GlaxoSmithKline, LLC. | $39.39 | 2 |
| Agios Pharmaceuticals, Inc. | $32.71 | 1 |
| Blueprint Medicines Corporation | $27.82 | 1 |
| Merck Sharp & Dohme Corporation | $23.02 | 1 |
| EISAI INC. | $18.66 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $18.64 | 1 |
By program year
Records — PY2024 (58)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.